Abstract |
Weak therapeutic responses and weak immune cytotoxic CD8 and CD4 response in chronic hepatitis B emphasize the necessity to find new therapeutic strategies especially as specific immunotherapy. Vaccination, whose principle was to widen immune repertoire, was used as a curative treatment of chronic hepatitis B. It would be the therapeutic procedure with the lowest cost and the potentially greatest benefit. Our purpose was to enhance the interest of therapeutic vaccination in chronic hepatitis B in order to debate later its usefulness in developing countries.
|
Authors | Héla Elloumi, Ahlem Souguir, Dalenda Arfaoui, Aïda Ben Slama, Souhir Sfar, Salem Ajmi |
Journal | La Tunisie medicale
(Tunis Med)
Vol. 83
Issue 12
Pg. 721-4
(Dec 2005)
ISSN: 0041-4131 [Print] Tunisia |
Vernacular Title | Interet de la vaccination au cours de l'hepatite chronique B. |
PMID | 16450937
(Publication Type: English Abstract, Journal Article, Review)
|
Chemical References |
|
Topics |
- Hepatitis B Vaccines
(therapeutic use)
- Hepatitis B, Chronic
(drug therapy)
- Humans
|